Business Standard

Lupin launches Clobazam Tablets

Image

Capital Market

On 10 May 2019

Pharma major Lupin announced the launch of Clobazam Tablets, 10 mg and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin's Clobazam Tablets, 10 mg and 20 mg is the generic version of Lundbeck Pharms, LLts Onfi Tablets, 10 mg and 20 mg. It is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 10 2019 | 12:28 PM IST

Explore News